4th Donor Selection & Cell Source Summit

4th Donor Selection & Cell Source Summit is organized by Hanson Wade and will be held from Dec 07 - 08, 2026 at The Westgate Hotel, San Diego, California, United States of America.

Description:
Spearheading Development of Gold Standard Donor Screening, Testing & Management to De-Risk Manufacturing, Improve Product Consistency & Performance & Meet Clinical Demand of High Quality Donor Material For Allogeneic Cell Therapies

Donor quality and strategy is the difference between promising allogeneic therapies and commercially viable products.

As more allogeneic programs progress into later-stage development, manufacturers are seeing first-hand how donor variability impacts yield, product consistency, cost of goods, and clinical performance. At the same time, regulators are demanding greater control and traceability of donor starting material, while investors increasingly expect evidence of scalable manufacturing. With competition from in vivo therapies intensifying, the industry can no longer afford to treat donor selection as a siloed upstream decision.

Fit-for-purpose donor strategies are emerging as a critical competitive advantage.

That's why the 4th Donor Selection & Cell Source Summit returns as the only dedicated forum focused exclusively on donor sourcing, screening, characterization, testing, and management for allogeneic cell therapies.